EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Renal Cell Carcinoma With Hemangioblastoma‐Like Features, Fibromyomatous Stroma, and TSC1 Mutation

Shiyun Yao iD, Jinghui Huang, Mingfa Wang, Chunji Quan iD

Case Reports in Medicine · 2026-01 · 2026 (1)

DOI: 10.1155/carm/3548941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Case Reports in Medicine, online erschienen am 23.08.2026. Verfasst von Shiyun Yao und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Hainan Medical University, Haikou, Hainan, China, hainmc.edu.cn. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal cell carcinoma (RCC) with fibromyomatous stroma (RCC‐FMS) was classified as an “emerging/provisional” entity in the 2016 WHO classification of tumors, specifically categorized as RCC with (vascular) fibromyomatous stroma. However, it was not included in the 2022 WHO classification. Renal cell carcinoma with hemangioblastoma (RCC‐HB)‐like features has also been reported infrequently in recent years. RCC‐HB‐like features and fibromyomatous stroma is quite rare, with only two reports in the literature. This report describes a rare tumor of RCC‐HB‐like features and fibromyomatous stroma associated with TSC1 mutations. A female patient was incidentally discovered a right renal mass during a routine physical examination conducted 2 weeks prior. Histology revealed that the tumor consisted of three distinct components: clear cell papillary renal cell tumor (CCPRCT)‐like areas, fibromyomatous stroma, and HB‐like areas. Immunohistochemical staining showed that the CCPRCT‐like components exhibited basolateral, cup‐shaped CAIX staining and were diffusely positive for AE1/AE3, CK7, and PAX‐8, partially positive for AMACR/P504S, and weakly positive for CD10. The fibromyomatous stroma was positive for H‐caldesmon, desmin, and SMA. In the HB‐like components, α‐inhibin, ERG, CD34, CAIX, and vimentin were all diffusely positive, CD10 was partially positive, and PAX‐8 showed scattered, weak positivity. Whether RCC‐HB features and fibromyomatous stroma can be regarded as a distinct subtype of RCC remains to be discussed by accumulation of more cases.

Schlagwörter

Stichwörter der Autor:innen

fibromyomatous stromahemangioblastomarenal cell carcinoma

Autor:innen und Institutionen

  • The First School of Clinical Medicine, Hainan Medical University, Haikou, Hainan, China, hainmc.edu.cn.
  • Department of Pathology, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China, hainmc.edu.cn.
  • Department of Radiology, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China, hainmc.edu.cn.
  • Department of Pathology, Hainan Women and Children's Medical Center, Haikou, Hainan, China.

ORCID-Profile: Shiyun Yao, Chunji Quan

Zitieren

APA

Yao, S., Huang, J., Wang, M., & Quan, C. (2026). Renal Cell Carcinoma With Hemangioblastoma‐Like Features, Fibromyomatous Stroma, and TSC1 Mutation. Case Reports in Medicine, 2026(1). https://doi.org/10.1155/carm/3548941

Vancouver

Yao S, Huang J, Wang M, Quan C. Renal Cell Carcinoma With Hemangioblastoma‐Like Features, Fibromyomatous Stroma, and TSC1 Mutation. Case Reports in Medicine. 2026;2026(1). doi:10.1155/carm/3548941

BibTeX
@article{Yao2026,
  author = {Yao, Shiyun and Huang, Jinghui and Wang, Mingfa and Quan, Chunji},
  title = {Renal Cell Carcinoma With Hemangioblastoma‐Like Features, Fibromyomatous Stroma, and TSC1 Mutation},
  journal = {Case Reports in Medicine},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/carm/3548941}
}
Kostenlos starten →